Failure of buspirone and verapamil to improve spasmodic torticollis.
Standard
Failure of buspirone and verapamil to improve spasmodic torticollis. / Naber, Dieter; Weinberger, D R; Gillespie, M; Chase, T N.
In: J NEUROPSYCH CLIN N, Vol. 4, No. 1, 1, 1992, p. 82-84.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Failure of buspirone and verapamil to improve spasmodic torticollis.
AU - Naber, Dieter
AU - Weinberger, D R
AU - Gillespie, M
AU - Chase, T N
PY - 1992
Y1 - 1992
N2 - The effects of buspirone and verapamil on spasmodic torticollis were investigated in two double-blind, placebo-controlled crossover studies. Buspirone was given in doses of 20-100 mg/day for 4 weeks to 14 patients; verapamil was given in doses of 40-100 mg/day for 3 weeks to 8 patients. Neither drug improved symptoms of the movement disorder (posture, motility, rigidity, tremor), pain, perceived stress, or mood, either in the whole group or in any individual patient.
AB - The effects of buspirone and verapamil on spasmodic torticollis were investigated in two double-blind, placebo-controlled crossover studies. Buspirone was given in doses of 20-100 mg/day for 4 weeks to 14 patients; verapamil was given in doses of 40-100 mg/day for 3 weeks to 8 patients. Neither drug improved symptoms of the movement disorder (posture, motility, rigidity, tremor), pain, perceived stress, or mood, either in the whole group or in any individual patient.
M3 - SCORING: Zeitschriftenaufsatz
VL - 4
SP - 82
EP - 84
JO - J NEUROPSYCH CLIN N
JF - J NEUROPSYCH CLIN N
SN - 0895-0172
IS - 1
M1 - 1
ER -